Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Islem Ben Hassine"'
Publikováno v:
Engenharia Agrícola, Vol 43, Iss 5 (2023)
ABSTRACT All horticultural regions of the world have fundamentally developed in the programmatic era through farmer impact and imaginative development practices. The methods described are used to monitor satisfaction and crop yields. Because of the q
Externí odkaz:
https://doaj.org/article/48df8bcd4ae34090ba45d8c27df89a36
This paper suggests a dual-band 28/38 GHz four element MIMO array based on dual-mode planar monopole antennas for 5G wireless applications. The design structure contains four planar monopole antennas; located at the corners on a 20×20 mm2 size Roger
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::246ce92195af810e66f07b3414b1dbaa
https://doi.org/10.21203/rs.3.rs-2260838/v1
https://doi.org/10.21203/rs.3.rs-2260838/v1
Autor:
Mouheb Teber, Islem Ben Hassine, Rayhane Ben lakhal, Hanene Gharbi, Ismail Soltani, Neila Ben Romdhane, Samia Menif, Salem Abbes, Hassiba Amouri, Hind Ben Hadj Othman, Ahlem Farrah, Hatem Bellaaj
Publikováno v:
Cancer Chemotherapy and Pharmacology. 79:737-745
Imatinib mesylate (IM) is considered as a highly effective therapy for chronic myeloid leukemia (CML) patients. However, a minority of patients fail to achieve optimal response due to impaired bioavailability of IM. The human organic cation transport
Autor:
Mouheb Teber, Hanen Gharbi, Kais Douzi, Islem Ben Hassine, Ghada Bouguerra, Samia Menif, Salem Abbes, Ismael Soltani
Publikováno v:
Functional & Integrative Genomics. 17:263-277
Targeted therapy in the form of selective breakpoint cluster region-abelson (BCR/ABL) tyrosine kinase inhibitor (imatinib mesylate) has successfully been introduced in the treatment of the chronic myeloid leukemia (CML). However, acquired resistance
Autor:
Hassiba Amouri, Hanene Gharbi, Ismail Soltani, Nourel Houda Toumi, Mouheb Teber, Samia Menif, Islem Ben Hassine, Ines Safra, Salima Abdennebi, Ahlem Farah, Hind Bel Haj Othmen, Slah Ouerhani, Salem Abbes
Publikováno v:
Pediatric Hematology and Oncology. 33:157-167
Recent genome-wide association studies (GWAS) focusing on pediatric acute lymphoblastic leukemia (ALL), the most common malignancy in children younger than 15 years old, have found evidence that single-nucleotide polymorphisms (SNPs) in IKZF1 (7p12.2
Molecular study of ABCB1 gene and its correlation with imatinib response in chronic myeloid leukemia
Autor:
Mouheb Teber, Hassiba Amouri, Hela Ghedira, Ismail Soltani, Samia Menif, Ahlem Farrah, Hind Ben Hadj Othman, Hanene Gharbi, Ines Safra, Yosra Ben Youssef, Islem Ben Hassine, Salem Abbes
Publikováno v:
Cancer chemotherapy and pharmacology. 80(4)
The introduction and success of imatinib mesylate have become a paradigm shift in chronic myeloid leukemia (CML) treatment. However, despite its high efficiency, resistance to imatinib has emerged as a significant problem, which may in part be caused